Chandrasekar Kandaswamy

Title: Innovations of Chandrasekar Kandaswamy

Introduction

Chandrasekar Kandaswamy is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-cancer drugs. With a total of three patents to his name, Kandaswamy has demonstrated a commitment to advancing medical science.

Latest Patents

One of his latest patents includes the anhydrous polymorphic form-I of Lenalidomide, an anti-cancer drug. The chemical name for Lenalidomide is 3-(4-amino-1-oxo-1,3-dihydro-isoindole-2-yl)-piperidine-2,6-dione. This patent discloses alternate methods for making the anhydrous polymorphic form-I of Lenalidomide, showcasing Kandaswamy's innovative approach to drug formulation.

Career Highlights

Chandrasekar Kandaswamy is currently associated with Natco Pharma Limited, a prominent pharmaceutical company. His work at Natco Pharma has allowed him to focus on developing effective treatments for cancer, contributing to the company's reputation in the industry.

Collaborations

Kandaswamy has collaborated with several professionals in his field, including Durga Prasad Konakanchi and Buchappa Gongalla. These collaborations have likely enhanced his research and development efforts, leading to successful innovations.

Conclusion

Chandrasekar Kandaswamy's contributions to the pharmaceutical industry, particularly in the development of anti-cancer drugs, highlight his role as an influential inventor. His patents and collaborations reflect his dedication to improving healthcare through innovative solutions.